3-drugs Canada Corner, Nashik, Maharashtra

3-Drugs is a well-known Service Provider of Clinical Development Services. It is engaged in offering various Clinical Development Services, such as Coordination Study Site Activity, Patient Recruitment, Pharmacovigilance Medical Writing, Phase IV Study, Post Approval Study and Site Management of The Phase II to Phase III. Our physicians, healthcare professionals and life scientists expertly handle the processing of hundreds of highly sophisticated clinical studies & products from a drug safety perspective. Various therapeutic areas are included under our offered Clinical Development Services.

3- Drugs is engaged in Coordination of Study Site Activity. It coordinates all the study site activity at its best. We operate very fast from getting study from the sponsor to approval from the ethics committee. We have the flexible business model, which allows to start the study and to complete the study before the study close out dates. Coordination Study Site Activity is undertaken by our professional experts. Moreover, we have the patient recruitment services, which double the patient recruitment rate at our site. We have become a notable Service Provider of Coordination Study Site Activity.  

Speedy recruitment of the subject is the most essential part of the any clinical trial to achieve success. 3-Drugs is equipped with the Patient Recruitment across the India. Our past record shows that we are the best in recruitment of the subject in all the global trials, which we have conducted earlier. We almost have double Patient Recruitment rate in any study we have completed till now. We are a preferred name when it comes to Patient Recruitment in India.

3-Drugs is engaged in offering excellent Pharmacovigilance Medical Writing. It is specializing in providing the following Pharmacovigilance Medical Writing services to global pharmaceutical companies- Single Case Processing (ICSRS and related services), Aggregate Report Writing, like Periodic Adverse Drug Experience Reports (PADERS), Periodic Safety Update Reports (PSURS), Development Safety Update Reports (DSURS), Annual Safety Reports (ASR) from the start. Our physicians, healthcare professionals and life scientists have expertly handled the processing of hundreds of highly sophisticated clinical studies and products from a drug safety perspective. These include the following therapeutic areas and form the basis of the Pharmacovigilance Medical Writing we offer : Oncology Dermatology Cardio-vascular Rheumatology Immunology Autoimmune diseases Metabolic disorders Psychiatric and CNS disorders pain

3-Drugs provide excellent service to all our pharma corporate to help them evaluate the safety of the drug in the Phase IV Study. We have dedicated team of expertise, which only focus on the Phase IV Clinical Study. We have become a prominent name when it comes to Phase IV Study. This has been possible because of our professional Phase IV Study Service.

We are engaged in providing Post Approval Study. Under our Post Approval Study, we provide drug utilization study, pharmaco-economic analysis, etc. We have conducted more than 100 Post Approval Study for various clinical establishments. We have become a well-known name in domain for offering Post Approval Study clinical service.

3-Drugs offer Site Management of The Phase II to Phase III. It is adept at managing every aspect of phase ii and phase iii trials. We offer a broad range of Site Management of The Phase II to Phase III services that allows us to provide capacity and experience in clinical trial management. The value of 3-Drugs clinical operations lies in the experience we bring to the client. As a result, we can provide strong site management and enrollment strategies. We consider the lead clinical research coordinators (LCRC) to be an integral part of the study. That is why; ours have an average of 5 to 6 years of clinical operations leadership experience in Site Management of The Phase II to Phase III. Our regional CRC model allows us to provide hands-on coverage to all regions of the country.

Investigator/Site : Subject Recruitment Support

SponsorCRO Clinical Project Management CRF Design Data management Design of Clinical Trial Logs ICF Design Independent Audit Pharmacovigilance Monitoring & Outsourcing Preparation of Investigator's Brochure Protocol Development Site Identification Translation And Back Translation of ICF   InvestigatorSite Final Study Report Development GCP training to Investigator and site staff Negotiation of site contractbudget Providing study coordinators (CRCs) Site initiation and close out activities Site Management And Study Supply Subject Recruitment support

SponsorCRO Clinical Project Management CRF Design Data management Design of Clinical Trial Logs ICF Design Independent Audit Pharmacovigilance Monitoring & Outsourcing Preparation of Investigator's Brochure Protocol Development Site Feasibility and Selection Site Identification Translation And Back Translation of ICF   InvestigatorSite Final Study Report Development GCP training to Investigator and site staff Institutional Ethics Committee Negotiation of site contractbudget Providing study coordinators (CRCs) Site initiation and close out activities Site Management And Study Supply Subject Recruitment support

SponsorCRO Clinical Project Management CRF Design Data management Design of Clinical Trial Logs ICF Design Independent Audit Pharmacovigilance Monitoring & Outsourcing Preparation of Investigator's Brochure Protocol Development Site Feasibility And Selection Site Identification   InvestigatorSite Final Study Report Development GCP training to Investigator and site staff Institutional Ethics Committee Negotiation of site contractbudget Providing study coordinators (CRCs) Site initiation and close out activities Site Management And Study Supply Subject Recruitment support